A detailed history of Citigroup Inc transactions in Avantor, Inc. stock. As of the latest transaction made, Citigroup Inc holds 421,955 shares of AVTR stock, worth $9.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
421,955
Previous 384,229 9.82%
Holding current value
$9.54 Million
Previous $9.82 Million 8.95%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$21.2 - $25.87 $799,791 - $975,971
37,726 Added 9.82%
421,955 $8.95 Million
Q1 2024

May 10, 2024

SELL
$21.37 - $26.07 $415,646 - $507,061
-19,450 Reduced 4.82%
384,229 $9.82 Million
Q4 2023

Feb 09, 2024

SELL
$17.15 - $23.08 $599,392 - $806,645
-34,950 Reduced 7.97%
403,679 $9.22 Million
Q3 2023

Nov 09, 2023

SELL
$20.23 - $23.33 $218,848 - $252,383
-10,818 Reduced 2.41%
438,629 $9.25 Million
Q2 2023

Aug 10, 2023

SELL
$18.72 - $21.54 $1.06 Million - $1.22 Million
-56,443 Reduced 11.16%
449,447 $9.23 Million
Q1 2023

May 11, 2023

SELL
$20.07 - $25.1 $4.97 Million - $6.21 Million
-247,604 Reduced 32.86%
505,890 $10.7 Million
Q4 2022

Feb 09, 2023

BUY
$19.22 - $22.8 $2.74 Million - $3.25 Million
142,373 Added 23.3%
753,494 $15.9 Million
Q3 2022

Nov 10, 2022

BUY
$19.6 - $32.33 $6.1 Million - $10.1 Million
311,131 Added 103.71%
611,121 $12 Million
Q2 2022

Aug 10, 2022

SELL
$29.35 - $34.19 $179,416 - $209,003
-6,113 Reduced 2.0%
299,990 $9.33 Million
Q1 2022

May 12, 2022

SELL
$32.56 - $40.56 $374,342 - $466,318
-11,497 Reduced 3.62%
306,103 $10.4 Million
Q4 2021

Feb 10, 2022

BUY
$36.93 - $42.14 $5.29 Million - $6.03 Million
143,148 Added 82.06%
317,600 $13.4 Million
Q3 2021

Nov 10, 2021

BUY
$35.36 - $44.01 $6.17 Million - $7.68 Million
174,452 New
174,452 $7.14 Million

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $15.2B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.